Literature DB >> 14512217

Abnormal luteal phase excitability of the motor cortex in women with premenstrual syndrome.

Mark J Smith1, Linda F Adams, Peter J Schmidt, David R Rubinow, Eric M Wassermann.   

Abstract

BACKGROUND: Premenstrual syndrome (PMS) involves an aberrant behavioral response to normal hormone secretion. Pathogenetic theories posit abnormal modulation of gamma-aminobutyric acid (GABA) transmission in the brain by neuroactive metabolites of progesterone (neurosteroids). In earlier transcranial magnetic stimulation (TMS) studies of the motor cortex, we showed that inhibition increases in the luteal phase, consistent with neurosteroid action at the GABA(A) receptor. Here, we studied women with PMS to see if their response to endogenous progesterone differed from that of control subjects.
METHODS: We studied nine women with PMS and 14 control subjects during the midfollicular and luteal phases with paired TMS. Subthreshold conditioning TMS was followed by test stimulation that produced a motor evoked potential (MEP) in a hand muscle. We gave pairs at each of seven intervals (2-10 msec) and unconditioned stimuli, measuring the amplitude ratio of the average MEP from the pairs at each interval to that from the unconditioned stimuli (ratio < 1 = inhibition).
RESULTS: Both groups showed the same follicular phase response to paired TMS. Control subjects showed more inhibition in the luteal phase. Women with PMS showed relative facilitation.
CONCLUSIONS: This is the first physiological evidence for an abnormal brain response to progesterone in PMS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512217     DOI: 10.1016/s0006-3223(02)01924-8

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  27 in total

1.  5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.

Authors:  Pedro E Martinez; David R Rubinow; Lynnette K Nieman; Deloris E Koziol; A Leslie Morrow; Crystal E Schiller; Dahima Cintron; Karla D Thompson; Khursheed K Khine; Peter J Schmidt
Journal:  Neuropsychopharmacology       Date:  2013-08-14       Impact factor: 7.853

2.  Orbitofrontal cortex activity related to emotional processing changes across the menstrual cycle.

Authors:  Xenia Protopopescu; Hong Pan; Margaret Altemus; Oliver Tuescher; Margaret Polanecsky; Bruce McEwen; David Silbersweig; Emily Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-24       Impact factor: 11.205

3.  Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder.

Authors:  Cynthia Neill Epperson; Brian Pittman; Kathryn Ann Czarkowski; Stephanie Stiklus; John Harrison Krystal; Christian Grillon
Journal:  Neuropsychopharmacology       Date:  2007-02-21       Impact factor: 7.853

4.  Neuroimaging evidence of cerebellar involvement in premenstrual dysphoric disorder.

Authors:  Andrea J Rapkin; Steven M Berman; Mark A Mandelkern; Daniel H S Silverman; Melinda Morgan; Edythe D London
Journal:  Biol Psychiatry       Date:  2010-11-18       Impact factor: 13.382

5.  Premenstrual dysphoric disorder: burden of illness and treatment update.

Authors:  Teri Pearlstein; Meir Steiner
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

Review 6.  Allopregnanolone as a mediator of affective switching in reproductive mood disorders.

Authors:  Crystal Edler Schiller; Peter J Schmidt; David R Rubinow
Journal:  Psychopharmacology (Berl)       Date:  2014-05-21       Impact factor: 4.530

7.  Premenstrual dysphoric disorder and the brain.

Authors:  C Neill Epperson
Journal:  Am J Psychiatry       Date:  2013-03       Impact factor: 18.112

Review 8.  The role of sex steroids in catamenial epilepsy and premenstrual dysphoric disorder: implications for diagnosis and treatment.

Authors:  Constance Guille; Susan Spencer; Idil Cavus; C Neill Epperson
Journal:  Epilepsy Behav       Date:  2008-03-17       Impact factor: 2.937

9.  Estrogen is necessary for 5alpha-pregnan-3alpha-ol-20-one (3alpha,5alpha-THP) infusion to the ventral tegmental area to facilitate social and sexual, but neither exploratory nor affective behavior of ovariectomized rats.

Authors:  C A Frye; J J Paris; M E Rhodes
Journal:  Pharmacol Biochem Behav       Date:  2008-08-23       Impact factor: 3.533

10.  Steroid hormone fluctuations and GABA(A)R plasticity.

Authors:  Jamie Maguire; Istvan Mody
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.